Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

1.60
Delayed Data
As of 11:37am ET
 0.00 / 0.00%
Today’s Change
1.45
Today|||52-Week Range
4.39
-54.15%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close1.60
Today’s open1.61
Day’s range1.54 - 1.63
Volume43,801
Average volume (3 months)38,292
Market cap$17.6M
Dividend yield--
Data as of 11:37am ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-398.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-26.84%
P/E ratio160.0
Price/Sales9.10
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...-0.13-4.96%
CYCCCyclacel Pharmaceuti...+0.04+0.99%
BLPHBellerophon Therapeu...+0.01+2.31%
HEBHemispherx Biopharma...+0.04+4.99%
Data as of 11:38am ET, 12/05/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$2.7M
Annual profit (last year)-$12.6M
Net profit margin-466.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts


Search for Jobs